- Home
- VRNA vs GMS Comparison
VRNA vs GMS Comparison
Compare VRNA & GMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNA
- GMS
- Stock Information
- Founded
- VRNA 2005
- GMS 1971
- Country
- VRNA United Kingdom
- GMS United States
- Employees
- VRNA N/A
- GMS N/A
- Industry
- VRNA Biotechnology: Pharmaceutical Preparations
- GMS
- Sector
- VRNA Health Care
- GMS
- Exchange
- VRNA Nasdaq
- GMS Nasdaq
- Market Cap
- VRNA 3.4B
- GMS 3.2B
- IPO Year
- VRNA 2017
- GMS 2016
- Fundamental
- Price
- VRNA $67.96
- GMS $78.24
- Analyst Decision
- VRNA Strong Buy
- GMS Hold
- Analyst Count
- VRNA 7
- GMS 7
- Target Price
- VRNA $57.14
- GMS $93.57
- AVG Volume (30 Days)
- VRNA 1.3M
- GMS 306.9K
- Earning Date
- VRNA 02-27-2025
- GMS 03-06-2025
- Dividend Yield
- VRNA N/A
- GMS N/A
- EPS Growth
- VRNA N/A
- GMS N/A
- EPS
- VRNA N/A
- GMS 5.45
- Revenue
- VRNA $5,624,000.00
- GMS $5,590,609,000.00
- Revenue This Year
- VRNA N/A
- GMS $3.58
- Revenue Next Year
- VRNA $571.44
- GMS $2.88
- P/E Ratio
- VRNA N/A
- GMS $14.97
- Revenue Growth
- VRNA 1127.95
- GMS 4.12
- 52 Week Low
- VRNA $11.39
- GMS $77.29
- 52 Week High
- VRNA $68.64
- GMS $105.54
- Technical
- Relative Strength Index (RSI)
- VRNA 76.88
- GMS 27.08
- Support Level
- VRNA $62.24
- GMS $82.60
- Resistance Level
- VRNA $65.50
- GMS $84.64
- Average True Range (ATR)
- VRNA 2.78
- GMS 1.75
- MACD
- VRNA 0.22
- GMS -0.33
- Stochastic Oscillator
- VRNA 94.86
- GMS 3.84
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
About GMS GMS Inc.
GMS Inc is a distributor of specialty building products including wallboard, suspended ceiling systems, ceilings, steel framing, and other complementary building products. The company serves its products to commercial new construction, commercial repair and remodel, residential new construction, and residential repair and remodel (R&R). Its geographical segment is Central, Midwest, New York, Northeast, Southern, Southeast, Southwest, Western and Canada, and Ames. The company generates maximum revenue from Wallboard products.